NCT02248233View on ClinicalTrials.gov

Nimodipine for Treating Acute Massive Cerebral Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Cerebral Infarction
Interventions
DRUG

Nimodipine

Jiangsu Jichuan Pharmaceutical Co., Ltd., Jiangsu Province, China

DRUG

Saline + citicoline

physiological saline + citicoline 2.0 g, once a day, via intravenous drip, for 10 consecutive days.

All Listed Sponsors
lead

Fengtian Hospital

OTHER

NCT02248233 - Nimodipine for Treating Acute Massive Cerebral Infarction | Biotech Hunter | Biotech Hunter